|
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1–4 inhibitor in patients with advanced solid tumors |
|
|
|
Titel: |
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1–4 inhibitor in patients with advanced solid tumors |
Auteur: |
Bahleda, R. Meric-Bernstam, F. Goyal, L. Tran, B. He, Y. Yamamiya, I. Benhadji, K.A. Matos, I. Arkenau, H.-T. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 31 () nr. 10 pagina's 1405-1412 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|